Macrocyclic Lanthanide Complexes for Time-Resolved Fluorophores

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for luminescent complexes that are stable under biological conditions, exhibit low non-specific interactions with proteins, and have long fluorescence lifetimes, suitable for use in multiplex assays and medical diagnostics.

Innovation Solution

Development of macrocyclic ligands and lanthanide complexes with hydroxy-containing aromatic building blocks, such as hydroxyisophthalamide moieties, which form stable luminescent metal ion complexes with long emission lifetimes and low non-specific binding to proteins, enabling their use in aqueous media for bioanalytical assays.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional organic fluorophores are used, then fluorescence detection is achieved, but fluorescence lifetime is too short for optimal discrimination from background fluorescence

Engineering Contradiction:
Improvediscrimination from background fluorescenceVSAvoidfluorescence lifetime
Core Design Contradiction:
Measurement precisionVSDuration of action of moving object

Solution Approach 1:

The patent changes the fundamental parameter of fluorescence lifetime by transitioning from organic fluorophores (nanosecond lifetime) to lanthanide chelate fluorophores (microsecond to millisecond lifetime). This parameter change enables time-resolved fluorimetry, allowing discrimination of long-lived lanthanide emission from short-lived background fluorescence, thereby resolving the technical contradiction between measurement precision and duration of action.

Inventive Principle:
Principle #35Parameter changes

2Duration of action of moving object

If lanthanide chelates are used for time-resolved fluorimetry, then long fluorescence lifetime is achieved, but the label must be washed from the probe and fluorescence developed in an enhancement solution

Engineering Contradiction:
Improvefluorescence lifetimeVSAvoidassay procedure complexity
Core Design Contradiction:
Duration of action of moving objectVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by pre-organizing the chelate structure with built-in water exclusion cavities and hydrophobic pockets that stabilize the lanthanide coordination sphere before the assay is performed. This pre-organization eliminates the need for post-labeling enhancement solutions and washing steps, as the chelate is already optimized for aqueous media performance, thereby reducing assay procedure complexity while maintaining long fluorescence lifetime.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If coordinatively unsaturated lanthanide chelates are used, then acceptable fluorescence in the presence of water is achieved, but stability under biological conditions is insufficient

Engineering Contradiction:
Improvefluorescence performance in aqueous mediaVSAvoidstability under biological conditions
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent employs composite materials by designing chelates that combine multiple functional components: macrocyclic ligands with hydroxy-containing aromatic building blocks, hydrophobic pockets for water exclusion, and pre-organized coordination geometries. This composite structure simultaneously achieves stable lanthanide binding, acceptable fluorescence in aqueous media, and enhanced stability under biological conditions, resolving the contradiction between reliability and compositional stability.

Inventive Principle:
Principle #40Composite materials

4Measurement precision

If conventional fluorescent labels are used, then detection is achieved, but non-specific binding to proteins occurs

Engineering Contradiction:
Improvedetection specificityVSAvoidnon-specific binding to proteins
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent introduces the lanthanide chelate as an intermediary between the probe and detection system. The chelate's unique photophysical properties (long lifetime, sharp emission lines) and stable coordination chemistry serve as a mediator that enables specific detection while minimizing non-specific protein binding, thereby resolving the contradiction between measurement precision and harmful non-specific interactions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These complexes provide high stability and solubility in aqueous media, low non-specific binding, and high quantum yields of luminescence, facilitating sensitive and specific detection of analytes in bioanalytical assays and medical diagnostics.

Implementation Method 1

The fluorophore is energy transfer coupled to the luminescent group

Methodology Applied
Scientific EffectEnergy transfer:

Implementation Method 2

high quantum yields of luminescence

Methodology Applied
Scientific EffectLuminescence: Luminescence

Implementation Method 3

time-resolved fluorimetry. According to this method, a chelated lanthanide metal with a long radiative lifetime is attached to a molecule of interest

Methodology Applied
Scientific EffectTime-resolved fluorimetry:

Data Source

PatentUS8507199B2Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
Publication Date: 2013.08.13 LUMIPHORE INC
  • US8507199B2 patent drawing
  • US8507199B2 patent drawing
  • US8507199B2 patent drawing

AI summary

The present invention provides a novel class of macrocyclic compounds as well as complexes formed between a metal (e.g., lanthanide) ion and the compounds of the invention. Preferred complexes exhibit high stability as well as high quantum yields of lanthanide ion luminescence in aqueous media without the need for secondary activating agents. Preferred compounds incorporate hydroxy-isophthalamide moieties within their macrocyclic structure and are characterized by surprisingly low, non-specific binding to a variety of polypeptides such as antibodies and proteins as well as high kinetic stability. These characteristics distinguish them from known, open-structured ligands.